ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Jan. 30, pages 57 and 90, and March 5, page 61: Kimberly Prather is a professor at the University of California, San Diego, not UC Davis.
March 5, page 55: Ute Deichmann is a she not a he, as stated in the article.
It came to my attention in a Dec. 19, 2011, New York Times article that there is a circumstantial link between asthma and increased used of acetaminophen. An interesting issue that the article raised seems to be depletion of glutathione. Based on work that my group at Allergan and our collaborators conducted some years ago (Exp. Eye Res. 1997,64, 767; Chem. Res. Toxicol.,DOI: 10.1021/tx9700735) as well as earlier work with amodiaquine, an antimalarial agent, and urushiol, an agent isolated from poison ivy that induces allergies, this is actually an expected observation.
We demonstrated that hydroquinone-like structures including p-aminoclonidine undergo a facile oxidation to a quinonelike structure and then add glutathione, thus depleting that compound. That is the same mechanism of induction of allergy found for both amodiaquine and urushiol—similar hydroquinone-like structures. Acetaminophen, a hydroquinone-like structure, probably undergoes a similar oxidation and is then rendered reactive to nucleophiles, including glutathione. This line of work is worth pursuing.
By Stephen A. Munk
CEO and president Ash Stevens Inc.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter